Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

<ul>
<li>Guangdong Huayan Robotics launched its Hongkong IPO aiming to raise up to HK$1.4B (~ US$ 175M). They are collaborative robotics company who development, manufacturing and sale collaborative robots and components.  </li>
<li>Guangdong Huayan Robotics intends to use the IPO proceeds for expanding production facilities, overseas business development and enhance R&amp;D capabilities.</li>
<li>Guangdong Huayan Robotics is a long-term growth story. We would recommend investors with a long-term investment horizon to consider the name, given the potential.</li>
</ul>


Guangdong Huayan Robotics launched its Hongkong IPO aiming to raise up to HK$1.4B (~ US$ 175M). They are collaborative robotics company who development, manufacturing and sale collaborative robots and components.  
Guangdong Huayan Robotics intends to use the IPO proceeds for expanding production facilities, overseas business development and enhance R&amp;D capabilities.
Guangdong Huayan Robotics is a long-term growth story. We would recommend investors with a long-term investment horizon to consider the name, given the potential.


Shenzhen Inovance Technology Co., (300124 CH)

Guangdong Huayan Robotics IPO: Investors With A Long Term Collaborative Mindset Must Consider